dc.contributor.author | Conseil exécutif, 105 | |
dc.coverage.spatial | Genève | en |
dc.date.accessioned | 2013-05-05T17:42:37Z | |
dc.date.available | 2013-05-05T17:42:37Z | |
dc.date.issued | 2000 | |
dc.identifier.govdoc | EB105/35 | |
dc.identifier.uri | https://iris.who.int/handle/10665/81109 | |
dc.description | Conseil exécutif, cent cinquième session, Point 8.1 de l’ordre du jour provisoire | en |
dc.description | 8 p. | en |
dc.language.iso | fr | en |
dc.publisher | Organisation mondiale de la Santé | en |
dc.subject | Food safety | en |
dc.subject | Pharmaceutical products | en |
dc.subject | Malaria | en |
dc.subject.mesh | Food Irradiation | en |
dc.subject.mesh | No-Observed-Adverse-Effect Level | en |
dc.subject.mesh | Pharmaceutical Preparations | en |
dc.subject.mesh | Reference Standards | en |
dc.subject.mesh | Vaccines | en |
dc.subject.mesh | Drug Residues | en |
dc.subject.mesh | Food Contamination | en |
dc.subject.mesh | Veterinary Drugs | en |
dc.subject.mesh | Malaria | en |
dc.subject.mesh | Health Care Reform | en |
dc.title | Rapport sur les réunions de comités d’experts et de groupes d'étude : Rapport du Secrétariat | en |
dc.type | Governing body documents | en |
dc.subject.meshqualifier | adverse effects | en |
dc.subject.meshqualifier | standards | en |
dc.subject.meshqualifier | prevention and control | en |
dc.subject.meshqualifier | drug therapy | en |
dc.subject.meshqualifier | organization and administration | en |
who.relation.languageVersion | 10665/80747 | en |
who.relation.languageVersion | 10665/78979 | en |
who.relation.languageVersion | 10665/66068 | en |
who.relation.languageVersion | 10665/81111 | en |
who.relation.languageVersion | 10665/82638 | en |
who.relation.languageVersion | 10665/78978 | en |
who.relation.languageVersion | 10665/80792 | en |